- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Du Pont to sell in vitro diagnostics unit
Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of
Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of Wilmington,DE.
The sale is part of Du Pont's plan to divest its Medical Productsbusinesses in order to pay for the repurchase of stock from Seagram(SCAN 6/7/95). The sale does not involve Du Pont's medical imagingfilm and PACS operations, however. Du Pont expects to announcea buyer for those businesses in the next four to six weeks.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
